Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy
Updates in surgical oncology from SIOG 2020
Critical issues in drug and biomarker development
OncoAlert and ecancer weekly roundup for October 26 - 31, 2020
Treating elderly cancer patients during the COVID-19 pandemic
Pragmatic geriatric assessment for cancer patients in Brazil
Updates in radiation oncology from SIOG 2020
Extreme hypofractionation with stereotactic body radiation therapy for elderly patients
Biomarker-driven clinical trials: promises and pitfalls
Key themes, highlights and importance of this year's IBCD 2020 meeting
How current assay approval policies are leading to unintended imprecision medicine
OncoAlert and ecancer weekly roundup for October 19-26, 2020